It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

Health

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
China in talks with Pfizer for generic COVID drug

Asia Pacific / Science & Health Jan 7, 2023

China in talks with Pfizer for generic COVID drug

Beijing is in talks with the drugmaker to secure a license that will allow domestic firms to manufacture and distribute a generic version of its Paxlovid antiviral drug.

No, vaccines aren’t making new COVID-19 variants worse

Commentary / World Jan 6, 2023

No, vaccines aren’t making new COVID-19 variants worse

by Faye Flam

The omicron sequel XBB.1.5 is driving a new wave of COVID-19 infections — and misinformation.

Cancer vaccine hunt finally makes progress

Commentary / World Jan 4, 2023

Cancer vaccine hunt finally makes progress

by Lisa Jarvis

A small study shows promise in deploying mRNA technology against melanoma — but fighting tumors is vastly more complex than tackling COVID-19.

How China’s ‘zero-COVID’ reversal is playing out on the ground

Asia Pacific Dec 28, 2022

How China’s ‘zero-COVID’ reversal is playing out on the ground

by Alyssa Chen

The change has brought an explosive surge of infections, drug shortages, and confusion and frustration among the population.

Return to a maskless world still fantasy for Japan

National Dec 27, 2022

Return to a maskless world still fantasy for Japan

by Dave Hueston

Some feel that much of the motivation for wearing face coverings now simply comes from wanting to fit in with the crowd with "appropriate behavior."

COVID-19 cases on the rise as Japan enters the holiday season

National Dec 26, 2022

COVID-19 cases on the rise as Japan enters the holiday season

by Kanako Takahara

JTB estimates that about 21 million people will travel domestically, up 16.7% from the previous year.

Japan medical bodies aim to develop tailored drugs to treat rare diseases

National / Science & Health Dec 25, 2022

Japan medical bodies aim to develop tailored drugs to treat rare diseases

Japanese researchers plan to develop tailored drugs and treatments for patients with extremely rare diseases.

Sri Lanka's cancer patients struggle amid economic chaos

Asia Pacific Dec 24, 2022

Sri Lanka's cancer patients struggle amid economic chaos

Hospitals across Sri Lanka are struggling to contend with severe drug shortages, which have worsened over the last eight months amid an economic crisis.

U.S. scales back pandemic response even as China's COVID surge raises alarm

World Dec 23, 2022

U.S. scales back pandemic response even as China's COVID surge raises alarm

by Josh Wingrove

The shift, driven by congressional penny-pinching, marks a political, economic and public health gamble.

How accurate are China's COVID-19 death numbers?

Asia Pacific Dec 22, 2022

How accurate are China's COVID-19 death numbers?

by David Stanway and Nancy Lapid

The country's classification system has raised concerns among experts and the public.

Injectable HIV treatment offers hope to Ugandan patients

World / Science & Health Dec 22, 2022

Injectable HIV treatment offers hope to Ugandan patients

Some hope the new treatment option could help to reduce the stigma HIV patients suffer, particularly gay men.

Another Crispr first: New treatment wipes out teen's cancer

Commentary / World Dec 21, 2022

Another Crispr first: New treatment wipes out teen's cancer

by Lisa Jarvis

Next-generation Crispr gene-editing was used to create a therapy that attacked a 13-year-old's stubborn leukemia.

« 1 … 12 13 14 … 246 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times